“Is there anything else you’d like to share about leukemia treatment?
I'm very excited because I think we’ll cure leukemia in my lifetime. We’ve already come so far. For example, before 2000, patients with Philadelphia chromosome-positive acute lymphoblastic leukemia had a survival rate of 10%. Targeted therapy improved that to 35% to 40%, but patients had to receive a stem cell transplant, which isn’t easy. But I’ve led research on a drug called ponatinib in combination with chemotherapy, and we’ve seen the survival rate jump to 80% without a transplant. Our next goal is to increase the survival rate to 90% and eliminate the need for chemotherapy by using a combination of targeted therapy and immunotherapy.”
Hey Manouche, , Thanks for sharing this encouraging article with us , , I hope Doc is right and a cure isn't too long off. As a Stem Cell recipient I'd say "it isn't easy" is somewhat understated and the fewer folk that need it in future the better as it remains a bit of a lottery though ongoing research is improving outcomes. I know my case helped in some small way as I had severe Stage 4 GVHD and needed extensive after care to pull me through. I hope that we see these great strides transferring to curing MPNs for future generations.
MPNs and leukemia’s cures will happen to OUR generation and not only to the future ones
“The latest method under investigation to attack leukemia is a bit like exterminating cockroaches: It’s a three-step process using cutting-edge technology to bait, trap, and kill leukemia cells at their root.”
Hello! It is very encouraging that i hear you say that MPNs and leukemia’s cures will happen to OUR generation. What are the signs that make you believe it?
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
AXSL1 gene mutation
Is a normal lifespan possible for PV patients?
